BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1981 related articles for article (PubMed ID: 31228940)

  • 21. RNA methylation-mediated LINC01559 suppresses colorectal cancer progression by regulating the miR-106b-5p/PTEN axis.
    Shi K; Yang S; Chen C; Shao B; Guo Y; Wu X; Zhao L; Yang X; Zhang Q; Yuan W; Sun Z
    Int J Biol Sci; 2022; 18(7):3048-3065. PubMed ID: 35541914
    [TBL] [Abstract][Full Text] [Related]  

  • 22. METTL3 Intensifies the Progress of Oral Squamous Cell Carcinoma via Modulating the m6A Amount of PRMT5 and PD-L1.
    Ai Y; Liu S; Luo H; Wu S; Wei H; Tang Z; Li X; Lv X; Zou C
    J Immunol Res; 2021; 2021():6149558. PubMed ID: 34476262
    [TBL] [Abstract][Full Text] [Related]  

  • 23. JNK Signaling Promotes Bladder Cancer Immune Escape by Regulating METTL3-Mediated m6A Modification of PD-L1 mRNA.
    Ni Z; Sun P; Zheng J; Wu M; Yang C; Cheng M; Yin M; Cui C; Wang G; Yuan L; Gao Q; Li Y
    Cancer Res; 2022 May; 82(9):1789-1802. PubMed ID: 35502544
    [TBL] [Abstract][Full Text] [Related]  

  • 24. METTL3/YTHDF2 m
    Xie H; Li J; Ying Y; Yan H; Jin K; Ma X; He L; Xu X; Liu B; Wang X; Zheng X; Xie L
    J Cell Mol Med; 2020 Apr; 24(7):4092-4104. PubMed ID: 32126149
    [TBL] [Abstract][Full Text] [Related]  

  • 25. m6A methyltransferase METTL3 maintains colon cancer tumorigenicity by suppressing SOCS2 to promote cell proliferation.
    Xu J; Chen Q; Tian K; Liang R; Chen T; Gong A; Mathy NW; Yu T; Chen X
    Oncol Rep; 2020 Sep; 44(3):973-986. PubMed ID: 32705223
    [TBL] [Abstract][Full Text] [Related]  

  • 26. USP13 functions as a tumor suppressor by blocking the NF-kB-mediated PTEN downregulation in human bladder cancer.
    Man X; Piao C; Lin X; Kong C; Cui X; Jiang Y
    J Exp Clin Cancer Res; 2019 Jun; 38(1):259. PubMed ID: 31200745
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methyltransferase-like 3 (METTL3) mediated N6-methyladenosine (m6A) modifications facilitate mir-25-3p maturation to promote gastrointestinal stromal tumors (GISTs) progression.
    Qian K; Xu W; Xia X; Ding J
    Genes Genomics; 2022 Dec; 44(12):1519-1530. PubMed ID: 36040683
    [TBL] [Abstract][Full Text] [Related]  

  • 28. METTL3 m6A-dependently promotes miR-21-5p maturation to accelerate choriocarcinoma progression via the HIF1AN-induced inactivation of the HIF1A/VEGF pathway.
    Ye K; Li L; Wu B; Wang D
    Genes Genomics; 2022 Nov; 44(11):1311-1322. PubMed ID: 36074324
    [TBL] [Abstract][Full Text] [Related]  

  • 29. METTL14 regulates M6A methylation-modified primary miR-19a to promote cardiovascular endothelial cell proliferation and invasion.
    Zhang BY; Han L; Tang YF; Zhang GX; Fan XL; Zhang JJ; Xue Q; Xu ZY
    Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):7015-7023. PubMed ID: 32633395
    [TBL] [Abstract][Full Text] [Related]  

  • 30. METTL3 promotes the progression of nasopharyngeal carcinoma through mediating M6A modification of EZH2.
    Meng QZ; Cong CH; Li XJ; Zhu F; Zhao X; Chen FW
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4328-4336. PubMed ID: 32373970
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cross talk between RNA N6-methyladenosine methyltransferase-like 3 and miR-186 regulates hepatoblastoma progression through Wnt/β-catenin signalling pathway.
    Cui X; Wang Z; Li J; Zhu J; Ren Z; Zhang D; Zhao W; Fan Y; Zhang D; Sun R
    Cell Prolif; 2020 Mar; 53(3):e12768. PubMed ID: 31967701
    [TBL] [Abstract][Full Text] [Related]  

  • 32. N6-Methyladenosine enhances the translation of ENO1 to promote the progression of bladder cancer by inhibiting PCNA ubiquitination.
    Shen C; Liu J; Xie F; Yu Y; Ma X; Hu D; Liu C; Wang Y
    Cancer Lett; 2024 Jul; 595():217002. PubMed ID: 38823761
    [TBL] [Abstract][Full Text] [Related]  

  • 33. N
    Jin H; Ying X; Que B; Wang X; Chao Y; Zhang H; Yuan Z; Qi D; Lin S; Min W; Yang M; Ji W
    EBioMedicine; 2019 Sep; 47():195-207. PubMed ID: 31409574
    [TBL] [Abstract][Full Text] [Related]  

  • 34. METTL3 promotes non-small-cell lung cancer growth and metastasis by inhibiting FDX1 through copper death-associated pri-miR-21-5p maturation.
    Qian S; Liu J; Liao W; Wang F
    Epigenomics; 2023 Dec; 15(23):1237-1255. PubMed ID: 38126112
    [TBL] [Abstract][Full Text] [Related]  

  • 35. METTL3 promotes non-small cell lung cancer (NSCLC) cell proliferation and colony formation in a m6A-YTHDF1 dependent way.
    Dou X; Wang Z; Lu W; Miao L; Zhao Y
    BMC Pulm Med; 2022 Aug; 22(1):324. PubMed ID: 36008805
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circular RNA circSLC8A1 acts as a sponge of miR-130b/miR-494 in suppressing bladder cancer progression via regulating PTEN.
    Lu Q; Liu T; Feng H; Yang R; Zhao X; Chen W; Jiang B; Qin H; Guo X; Liu M; Li L; Guo H
    Mol Cancer; 2019 Jun; 18(1):111. PubMed ID: 31228937
    [TBL] [Abstract][Full Text] [Related]  

  • 37. METTL3/IGF2BP2 axis affects the progression of colorectal cancer by regulating m6A modification of STAG3.
    Yi J; Peng F; Zhao J; Gong X
    Sci Rep; 2023 Oct; 13(1):17292. PubMed ID: 37828232
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methyltransferase like 3 promotes colorectal cancer proliferation by stabilizing CCNE1 mRNA in an m6A-dependent manner.
    Zhu W; Si Y; Xu J; Lin Y; Wang JZ; Cao M; Sun S; Ding Q; Zhu L; Wei JF
    J Cell Mol Med; 2020 Mar; 24(6):3521-3533. PubMed ID: 32039568
    [TBL] [Abstract][Full Text] [Related]  

  • 39. METTL3 promotes IL-1β-induced degeneration of endplate chondrocytes by driving m6A-dependent maturation of miR-126-5p.
    Xiao L; Zhao Q; Hu B; Wang J; Liu C; Xu H
    J Cell Mol Med; 2020 Dec; 24(23):14013-14025. PubMed ID: 33098220
    [TBL] [Abstract][Full Text] [Related]  

  • 40. m
    Shen C; Xuan B; Yan T; Ma Y; Xu P; Tian X; Zhang X; Cao Y; Ma D; Zhu X; Zhang Y; Fang JY; Chen H; Hong J
    Mol Cancer; 2020 Apr; 19(1):72. PubMed ID: 32245489
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 100.